For generations, a diagnosis of an inherited or progressive retinal condition, from retinitis pigmentosa and macular degeneration to Stargardt disease, came with a single, devastating prognosis: irreversible vision loss.
Today, that narrative is fundamentally changing. As the global community marks World Retina Week (September 21 to 27), a convergence of gene editing, advanced biotechnology, and grassroots advocacy is rewriting the future of eye care.
In South Africa, under the theme "Living Well with Sight Loss", Retina South Africa is spearheading this shift, bridging the gap between revolutionary genomic breakthroughs and real-world support to ensure a diagnosis no longer means a life sentence of declining independence.
The biotechnology revolution
The human retina is a delicate, multi-layered tissue lining the back of the eye, responsible for capturing light and converting it into neural signals for the brain.
When genetic mutations or metabolic diseases disrupt retinal function, photoreceptor cells gradually degenerate.
Because the retina is an extension of the central nervous system, damaged photoreceptor cells historically could not be repaired or replaced.
However, because doctors can access the eye directly, and because its natural defences prevent dangerous inflammation, it has become the ideal testing ground for revolutionary gene therapies.
Key breakthrough frontiers
- Gene Replacement Therapy: Pioneer treatments such as voretigene neparvovec (Luxturna) deliver functional copies of missing genes directly beneath the retina using modified adeno-associated viral vectors and can improve functional vision in eligible patients.
- Precision Gene Editing (CRISPR): When mutated genes are too large to deliver through standard methods, scientists are testing CRISPR gene editing to repair the damaged DNA directly inside eye cells.
- Optogenetics and Stem Cell Therapy: For patients who have already lost the majority of their photoreceptor cells, optogenetics uses gene therapy to convert surviving non-photoreceptor retinal cells into light-sensitive units, while stem-cell-derived retinal pigment epithelium (RPE) patches are actively being tested to rebuild degraded retinal tissue.
Making eye treatments accessible
While international laboratories pioneer advanced therapies, the critical challenge remains local access and diagnostic infrastructure.
In South Africa, gene therapy cannot begin without precision diagnostics.
Retina South Africa collaborates closely with researchers at the University of Cape Town (UCT) to map specific genetic mutations across diverse local populations.
Identifying the exact genetic defect via next-generation sequencing (NGS) is the essential first step toward clinical trial qualification and targeted treatment matching.
“A progressive retinal condition changes how you see the world. It does not have to take away your place in it,” says Claudette Medefindt, national secretary and head of science at Retina South Africa.
“There is support available today, and science is moving faster than many patients realise. Our job is to make sure no South African walks that journey alone.”
Beyond diagnostic pipelines, systemic challenges like public-sector availability and trial equity persist. Organisations across the continent continue advocating for clinical trials, equitable drug pricing and broader public-health infrastructure.
Providing real support for sight loss
While biotechnology builds the future, thousands of individuals live with sight loss today.
A diagnosis of retinitis pigmentosa, AMD, Stargardt disease, Usher syndrome or diabetic retinopathy can feel overwhelming.
Founded in 1980, Retina South Africa stands as the country’s primary patient-led non-profit dedicated exclusively to retinal conditions. Operating across all nine provinces, the organisation serves more than 3,000 members through a multi-faceted approach:
Psychosocial and peer support: Professional counselling and peer mentorship for individuals and families adjusting to a new diagnosis.
Assistive technology and workplaces: Guidance on screen readers, magnification tools, high-contrast lighting and employer accommodation strategies.
Multilingual community outreach: Educational workshops, disability grant guidance and online learning modules like the "Living Well" with "Vision Loss" workshop series.
Adaptive sports: Para-sport initiatives designed to rebuild physical confidence, orientation and community connections.
"Sight loss is not a reason to step out of work, sport or public life. It is a reason to get the right tools and the right people around you." Mariza Jürgens, vice chairperson, Retina South Africa.
Practical guide: Protecting and preserving your vision
While inherited conditions stem from genetic factors, everyday lifestyle choices play a massive role in protecting the blood vessels of your retina and delaying the onset of acquired conditions like diabetic retinopathy and wet or dry AMD.
Comprehensive dilated exams: Schedule annual eye checks after age 40 (or earlier if you have diabetes or higher risk factors). Early stages of retinal degeneration often cause no pain or obvious early symptoms.
UV and blue light shielding: Wear 100% UV-blocking sunglasses (UV400) whenever you are outdoors. High exposure to UV light accelerates oxidative stress and damage in the macula.
Metabolic health and diet: Eat leafy greens rich in lutein and zeaxanthin, consume omega-3 fatty acids and keep blood sugar level. The tiny blood vessels in the retina are highly vulnerable to high blood glucose and systemic inflammation.
Smoking cessation: Avoid smoking completely. Smoking doubles or triples your risk of developing AMD.
Looking ahead
World Retina Week highlights a key transformation in modern medicine: inherited retinal conditions are moving from untreatable diagnoses to solvable genetic challenges.
By bridging the gap between cutting-edge genomic research and daily community support, patient-led organisations are ensuring that as science advances, no one walks the journey toward sight restoration alone.
alyssia.birjalal@nationalmg.co.za